AceCann

AceCann is a Portuguese medical cannabis company that has assembled a strong management team with diverse backgrounds, including over +60 years of healthcare/pharma experience, +11 years operating medical cannabis companies in Canada and Portugal, and +14 years operating with technology/data business. The company's focus lies in the cultivation, processing, extraction, and R&D of organic medical cannabis. AceCann's scope of action includes building a cost-efficient, scalable, and high-quality organic indoor cultivation and extraction facility near Lisbon, as well as engaging in therapeutics research and development, with a focus on new medical delivery forms for cannabis, in collaboration with local and international universities. Founded in 2019 and headquartered in Portugal, AceCann secured a noteworthy $15.00M Seed Round investment on 12 October 2021, with contributions from Casa Verde Capital, LINCE CAPITAL, Marc Gare, Frank Cid, Sebastian De La Rosa, Chris Mayle. With an adaptable structure designed to thrive in dynamic markets, AceCann aims to capitalize on the evolving landscape of medical cannabis and swiftly adapt to market demands and needs.